Biogen Inc. (NASDAQ:BIIB)

An analysis of the financial metrics from 2006 to 2022 reveals a significant transformation in the relationship between the share price and operating profitability. While both the share price and operating profit per share experienced substantial growth over the period, the Price to Operating Profit (P/OP) ratio underwent a long-term contraction, indicating that earnings growth outpaced price appreciation for much of the timeline.

Initial Valuation Compression (2006–2010)

A sharp downward trend in the P/OP ratio is observed during the early period, falling from a peak of 66.33 in 2006 to 11.26 by 2010. This compression was driven by a rapid increase in operating profit per share, which rose from 0.69 to 4.80, while the share price remained relatively stable in comparison, suggesting a correction from an initially high valuation multiple to a more fundamental-based valuation.

Mid-Term Growth and Volatility (2011–2015)

The period between 2011 and 2015 was characterized by significant share price escalation, reaching a peak of 391.12 in 2015. During this window, the P/OP ratio exhibited increased volatility, spiking to 28.29 in 2014 before retreating. This phase reflects a period where market expectations and price growth occasionally exceeded the pace of operational profit increases.

Operational Peak and Ratio Stabilization (2016–2022)

From 2016 onward, the P/OP ratio remained consistently low, fluctuating between 8.34 and 13.70. Operating profit per share reached its historical zenith of 40.46 in 2020, which coincided with the lowest observed P/OP ratio of 8.34. The final years of the sequence show a simultaneous decline in both share price and operating profit per share, with the P/OP ratio stabilizing at 11.39 by 2022.

Overall, the data demonstrates a transition from a high-multiple growth expectation in 2006 to a more mature valuation profile. The steady climb of operating profit per share over fifteen years acted as a primary driver in lowering the P/OP ratio, effectively grounding the share price in operational performance.